heptaminol has been researched along with Coronary Disease in 3 studies
Heptaminol: An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DERNIER, J | 1 |
| CLOETENS, W | 1 |
| Kühn, P | 1 |
| Probst, P | 1 |
| Berthiau, F | 1 |
| Garnier, D | 1 |
| Argibay, JA | 1 |
| Seguin, F | 1 |
| Pourrias, B | 1 |
| Grivet, JP | 1 |
| Le Pape, A | 1 |
3 other studies available for heptaminol and Coronary Disease
| Article | Year |
|---|---|
[Clinical use of heptaminol chlorhydrate].
Topics: Amino Alcohols; Anti-Arrhythmia Agents; Cardiotonic Agents; Cardiovascular Diseases; Coronary Diseas | 1961 |
[Hemodynamics and myocardial metabolism in coronary disease during beta receptor stimulation and administration of postassium magnesium aspartate (PMA)].
Topics: Adrenergic beta-Agonists; Aspartic Acid; Coronary Disease; Heart; Hemodynamics; Heptaminol; Humans; | 1975 |
Decrease in internal H+ and positive inotropic effect of heptaminol hydrochloride: a 31P n.m.r. spectroscopy study in rat isolated heart.
Topics: Alkalosis; Amino Alcohols; Animals; Coronary Disease; Heart; Heptaminol; Hydrogen-Ion Concentration; | 1989 |